iZafe Group AB Series B Cash Flow Conversion Efficiency

Latest as of March 2026: -0.190x

iZafe Group AB Series B cash flow conversion efficiency. Based on the latest financial reports, iZafe Group AB Series B (IZAFE-B) has a cash flow conversion efficiency ratio of -0.190x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-4.65 Million ≈ $-500.74K USD) by net assets (Skr24.47 Million ≈ $2.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of iZafe Group AB Series B (2012–2025)

Cash flow conversion efficiency of iZafe Group AB Series B from 2012 to 2025. This chart illustrates how iZafe Group AB Series B's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for iZafe Group AB Series B for real-time trading data and today's change.

iZafe Group AB Series B Cash Flow Conversion Ratio Explained

iZafe Group AB Series B cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

iZafe Group AB Series B Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of iZafe Group AB Series B ranked by their cash flow conversion efficiency. Also see IZAFE-B market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Concord Medical Services Holdings NYSE:CCM	0.009x
Asuransi Dayin Mitra Tbk JK:ASDM	-0.007x
Rewardle Holdings Ltd AU:RXH	-0.038x
FSBM Holdings Bhd KLSE:9377	-0.082x
Ihlas Ev Aletleri Imalat Sanayi ve Ticaret AS IS:IHEVA	0.009x
Guideline Geo AB (publ) ST:GGEO	0.072x
Lovable Lingerie Limited NSE:LOVABLE	0.012x
ShreeOswal Seeds And Chemicals Limited NSE:OSWALSEEDS	0.007x

Annual Cash Flow Conversion Efficiency for iZafe Group AB Series B (2012–2025)

The table below shows the annual cash flow conversion efficiency of iZafe Group AB Series B from 2012 to 2025. Review cash generation quality of iZafe Group AB Series B to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr11.69 Million ≈ $1.26 Million	Skr-14.56 Million ≈ $-1.57 Million	-1.246x	-6.74%
2024-12-31	Skr9.73 Million ≈ $1.05 Million	Skr-11.36 Million ≈ $-1.22 Million	-1.167x	-162.91%
2023-12-31	Skr25.35 Million ≈ $2.73 Million	Skr-11.26 Million ≈ $-1.21 Million	-0.444x	+19.39%
2022-12-31	Skr38.96 Million ≈ $4.19 Million	Skr-21.46 Million ≈ $-2.31 Million	-0.551x	+33.02%
2021-12-31	Skr40.73 Million ≈ $4.38 Million	Skr-33.49 Million ≈ $-3.60 Million	-0.822x	+1.40%
2020-12-31	Skr29.46 Million ≈ $3.17 Million	Skr-24.57 Million ≈ $-2.64 Million	-0.834x	-100.85%
2019-12-31	Skr36.89 Million ≈ $3.97 Million	Skr-15.32 Million ≈ $-1.65 Million	-0.415x	-197.93%
2018-12-31	Skr10.12 Million ≈ $1.09 Million	Skr-1.41 Million ≈ $-151.74K	-0.139x	+58.08%
2017-12-31	Skr11.19 Million ≈ $1.20 Million	Skr-3.72 Million ≈ $-400.22K	-0.332x	+58.28%
2016-12-31	Skr5.42 Million ≈ $582.96K	Skr-4.32 Million ≈ $-464.47K	-0.797x	-292.09%
2015-12-31	Skr8.72 Million ≈ $938.85K	Skr-1.77 Million ≈ $-190.78K	-0.203x	-121.50%
2014-12-31	Skr9.04 Million ≈ $973.08K	Skr-829.55K ≈ $-89.27K	-0.092x	-13.91%
2013-12-31	Skr11.69 Million ≈ $1.26 Million	Skr-941.32K ≈ $-101.30K	-0.081x	+6.07%
2012-12-31	Skr18.92 Million ≈ $2.04 Million	Skr-1.62 Million ≈ $-174.55K	-0.086x	--

About iZafe Group AB Series B

ST:IZAFE-B Sweden Medical Instruments & Supplies

Market Cap

$10.84 Million

Skr100.69 Million SEK

Market Cap Rank

#26716 Global

#565 in Sweden

Share Price

Skr0.25

Change (1 day)

-8.15%

52-Week Range

Skr0.25 - Skr0.70

All Time High

Skr16.60